Literature DB >> 9236733

Mixed anxiety and depression: from theory to practice.

J P Boulenger1, M Fournier, D Rosales, Y J Lavallée.   

Abstract

The 10th International Classification of Disease (ICD-10) introduced the concept of mixed anxiety-depression to define patients presenting both anxiety and depressive symptoms of limited number and/or intensity, not sufficiently severe to fulfill criteria for a specific diagnosis of depressive or anxiety disorder. Epidemiologic surveys have shown that these patients may display significant levels of functional impairment, have unexplained somatic symptoms and a high use of nonpsychiatric medical care, have long-lasting symptoms, and are at risk for more severe psychiatric disorders. A DSM-IV field trial concluded that patients with affective-symptoms not meeting thresholds for DSM-III-R disorders were at least as common as patients with anxiety or mood disorders, and that their symptoms were associated with significant distress or impairment. Although some of these patients present residual symptoms from previous psychiatric episodes and may request treatment specific to these conditions, it is not known if those without a psychiatric history could benefit from pharmacologic or psychological treatments usually used in mild outpatient cases.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9236733

Source DB:  PubMed          Journal:  J Clin Psychiatry        ISSN: 0160-6689            Impact factor:   4.384


  2 in total

1.  "Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories.

Authors:  Koen Demyttenaere; Anne Verhaeghen; Nicolas Dantchev; Luigi Grassi; Angel L Montejo; David G S Perahia; Deborah Quail; Catherine Reed; Andre Tylee; Michael Bauer
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2009

Review 2.  The relevance of 'mixed anxiety and depression' as a diagnostic category in clinical practice.

Authors:  Hans-Jürgen Möller; Borwin Bandelow; Hans-Peter Volz; Utako Birgit Barnikol; Erich Seifritz; Siegfried Kasper
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2016-03-22       Impact factor: 5.270

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.